0000313143-14-000073.txt : 20140724 0000313143-14-000073.hdr.sgml : 20140724 20140724191253 ACCESSION NUMBER: 0000313143-14-000073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140722 FILED AS OF DATE: 20140724 DATE AS OF CHANGE: 20140724 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0330 BUSINESS ADDRESS: STREET 1: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davies Kent J CENTRAL INDEX KEY: 0001351454 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 14992397 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2014-07-22 0 0000313143 HAEMONETICS CORP HAE 0001351454 Davies Kent J 400 WOOD ROAD BRAINTREE MA 02184 0 1 0 0 President, Global Markets Common Stock 2014-07-22 4 A 0 3402.0 0.0 A 3402 D Non-Qualified Stock Option (right to buy) 35.272 2014-07-22 4 A 0 34271.0 0.0 A 2015-07-25 2024-07-22 Common Stock 34271 34271 D Performance Shares 0.0 2014-07-22 4 A 0 19577.0 0.0 A 2017-03-31 2017-12-31 Common Stock 19577 19577 D Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan. Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant. Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d). By: Alexander Steffan For: Kent Davies 2014-07-24